Cocrystal Pharma Reports Third Quarter Financial Results and Provides an Update on Development Programs and Milestones

NEXT STORY
Summit Therapeutics Inc Reports Financial Results and Operational Progress for the Third Quarter and Nine Months Ended September 30, 2021
PREV STORY
Rhythm Pharmaceuticals Announces FDA Acceptance for Filing and Priority Review of Supplemental New Drug Application for IMCIVREE® (setmelanotide) for Patients with Bardet-Biedl Syndrome and Alström Syndrome
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

TLC Earns Highest Ranks in Corporate Governance Evaluation for 5th Consecutive Year

author_avatar
NASDAQ Market News

Novartis Phase III CANTOS study demonstrates that targeting inflammation with ACZ885 reduces cardiovascular risk

Study showed a significant 15% reduction of major adverse cardiovascular events (MACE) in people ...

author_avatar
NASDAQ Market News

Global Orthopedic Implants Market Size to Grow Above USD 73.5 Billion by 2026, According to Facts & Factors

author_avatar
NASDAQ Market News